Results 121 to 130 of about 16,636 (201)

A nagydózisú caspofungin terápia hatékonyságának in vivo vizsgálata Candida albicans izolátumok ellen

open access: yes, 2018
Az invazív gombafertőzések száma az elmúlt pár évtizedben drasztikusan növekedett, mára komoly súlyú, megoldásra váró egészségügyi problémává váltak. Ezt az a tény is megerősíti, hogy a mortalitás igen magas, egyes fajok esetében a 60-70%-ot is elérheti.
Dürgő, Éva
core  

Exploring Early Antifungal Activity of Rezafungin as a Stepping-Stone for Shorter Treatment Duration for Candidemia: Pooled Analysis of 2 Randomized Trials. [PDF]

open access: yesOpen Forum Infect Dis
Ostrosky-Zeichner L   +7 more
europepmc   +1 more source

Synergistic activity of caspofungin and posaconazole against <i>Candida</i> (<i>Candidozyma</i>) <i>auris</i> biofilms based on phenotypic, transcriptomic, and <i>in vivo</i> insights. [PDF]

open access: yesMicrobiol Spectr
Kovács F   +11 more
europepmc   +1 more source

Rezafungin exhibits anti-biofilm properties against fungal biofilms in vitro. [PDF]

open access: yesJ Antimicrob Chemother
Abduljalil H   +7 more
europepmc   +1 more source

Model-dependent efficacy of sequential phage-antibiotic-antifungal therapy against dual-species biofilms. [PDF]

open access: yesBiofilm
Gliźniewicz M   +5 more
europepmc   +1 more source

The siderophore transporter Sit1 is involved in the uptake of caspofungin by <i>Candida albicans</i>. [PDF]

open access: yesAntimicrob Agents Chemother
Pedras A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy